Clinical Immunology

Groundbreaking Michigan Medicine Study Reveals Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Targeting the Gut-Liver Axis

Executive Overview In a significant medical breakthrough that could reshape the therapeutic landscape for metabolic disorders, researchers at Michigan Medicine have successfully demonstrated that an experimental compound can reverse severe...